Leadership
Piton Therapeutics is led by a seasoned and mission-driven leadership team with a proven track record in biotech innovation, drug development, and company building. Our executives bring together deep scientific expertise, strategic insight, and operational excellence to drive Piton’s vision forward. United by a shared commitment to transforming patient care through precision medicine and AI-powered discovery, our team is dedicated to delivering breakthrough therapeutics for some of the most challenging unmet clinical needs.
Nigel J. B. MacClancy
Chief Business Officer
& Acting CEO
Paul Miller, Ph.D.
Chief Scientific Officer
William J. Hoekstra, Ph.D.
Medicinal Chemistry Director
Peter LaCrosse
Chief Operating Officer
Brad Rosenblum
Chief Financial Officer
Ruchi Jain, Ph.D.
Principal Scientist
Michael Hadjisavas, Ph.D.
Board Member, Corp Dev
Robert Mills, Ph.D.
Scientific Director
Eric Wang, Ph.D.
Head of Data & AI Sciences
Learn about Piton’s AI-powered platform
At Piton Therapeutics, we are revolutionizing precision medicine through our state-of-the-art AI-powered platform, unlocking novel small-molecule therapeutics that target the gut-brain axis with unparalleled specificity.